Biotech Values

[ciotera]

I agree, in general.
However, even post elvitegravir quad, Isentress may have a play in a nuke sparing fixed dose regimen (with say Prezista and Intelence). I think now that there is Prezista, tolerability focus will shift from PIs (which caused the demise of Kaletra) to NRTIs.